1. Home
  2. TISI vs IFRX Comparison

TISI vs IFRX Comparison

Compare TISI & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TISI
  • IFRX
  • Stock Information
  • Founded
  • TISI 1973
  • IFRX 2007
  • Country
  • TISI United States
  • IFRX Germany
  • Employees
  • TISI N/A
  • IFRX N/A
  • Industry
  • TISI Other Consumer Services
  • IFRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TISI Consumer Discretionary
  • IFRX Health Care
  • Exchange
  • TISI Nasdaq
  • IFRX Nasdaq
  • Market Cap
  • TISI 93.7M
  • IFRX 89.5M
  • IPO Year
  • TISI N/A
  • IFRX 2017
  • Fundamental
  • Price
  • TISI $20.30
  • IFRX $1.52
  • Analyst Decision
  • TISI
  • IFRX Strong Buy
  • Analyst Count
  • TISI 0
  • IFRX 2
  • Target Price
  • TISI N/A
  • IFRX $13.50
  • AVG Volume (30 Days)
  • TISI 34.3K
  • IFRX 88.8K
  • Earning Date
  • TISI 11-07-2024
  • IFRX 10-30-2024
  • Dividend Yield
  • TISI N/A
  • IFRX N/A
  • EPS Growth
  • TISI N/A
  • IFRX N/A
  • EPS
  • TISI N/A
  • IFRX N/A
  • Revenue
  • TISI $849,064,000.00
  • IFRX $113,022.00
  • Revenue This Year
  • TISI N/A
  • IFRX $311.47
  • Revenue Next Year
  • TISI N/A
  • IFRX $227.11
  • P/E Ratio
  • TISI N/A
  • IFRX N/A
  • Revenue Growth
  • TISI N/A
  • IFRX N/A
  • 52 Week Low
  • TISI $5.05
  • IFRX $1.14
  • 52 Week High
  • TISI $26.77
  • IFRX $2.10
  • Technical
  • Relative Strength Index (RSI)
  • TISI 53.42
  • IFRX 52.54
  • Support Level
  • TISI $18.19
  • IFRX $1.45
  • Resistance Level
  • TISI $23.66
  • IFRX $1.60
  • Average True Range (ATR)
  • TISI 2.43
  • IFRX 0.07
  • MACD
  • TISI -0.43
  • IFRX 0.00
  • Stochastic Oscillator
  • TISI 26.06
  • IFRX 67.65

About TISI Team Inc.

Team Inc is a provider of specialty industrial services, including inspection, engineering assessment and mechanical repair and remediation required in maintaining high temperature and high-pressure piping systems and vessels that are utilized in refining, petrochemicals, and others. The company operates in two segments namely Inspection and Heat Treating Group and Mechanical Services Group. Inspection and Heat Treating Group provides non-destructive testing services for the process, pipeline and power sectors and others. The Mechanical Services Group provides call-out and turnaround services under both on-stream and shut down circumstances.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: